ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,860,662 | -15.4% | 1,813,759 | +2.3% | 0.00% | -100.0% |
| Q2 2023 | $23,479,181 | -2.7% | 1,773,352 | +0.0% | 0.00% | 0.0% |
| Q1 2023 | $24,130,380 | -32.1% | 1,772,989 | -2.5% | 0.00% | 0.0% |
| Q4 2022 | $35,525,655 | +6.5% | 1,819,030 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $33,358,000 | -0.6% | 1,751,100 | +7.5% | 0.00% | 0.0% |
| Q2 2022 | $33,569,000 | -29.3% | 1,629,586 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $47,499,000 | -3.8% | 1,476,042 | +39.1% | 0.00% | 0.0% |
| Q4 2021 | $49,392,000 | +195.5% | 1,060,810 | +71.4% | 0.00% | – |
| Q3 2021 | $16,714,000 | +26.5% | 619,031 | +20.2% | 0.00% | – |
| Q2 2021 | $13,209,000 | -44.3% | 514,975 | -25.8% | 0.00% | -100.0% |
| Q1 2021 | $23,711,000 | +7.6% | 693,751 | +6.4% | 0.00% | 0.0% |
| Q4 2020 | $22,043,000 | +109.6% | 651,778 | +52.9% | 0.00% | – |
| Q3 2020 | $10,517,000 | – | 426,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,706,663 | $126,694,000 | 24.48% |
| MPM BioImpact LLC | 2,355,557 | $80,513,000 | 10.12% |
| Boxer Capital, LLC | 4,345,016 | $148,513,000 | 5.04% |
| RA Capital Management | 4,417,258 | $150,982,000 | 2.28% |
| Ally Bridge Group (NY) LLC | 322,794 | $11,033,000 | 2.12% |
| Asymmetry Capital Management, L.P. | 102,286 | $3,496,000 | 1.81% |
| RTW INVESTMENTS, LP | 2,762,791 | $94,432,000 | 1.47% |
| COWEN AND COMPANY, LLC | 588,238 | $20,106,000 | 1.38% |
| Artal Group S.A. | 1,094,047 | $37,395,000 | 0.66% |
| HighVista Strategies LLC | 19,804 | $677,000 | 0.50% |